() experienced a significant drop in short interest during the month of march. On March 31, there were 1,200 short shares, which is 86.2% less than the 8,700 shares on March 15. The days-to-cover is currently 0.0 based on an average trading of 1,417.300 shares.
CNBX Pharmaceuticals Stock Performance
The price of the stock remained unchanged at $0.03 on Friday. The stock was traded at a volume of 620,315 compared to the average of 420135. The 50-day moving price of the firm is $0.07, and its 200 day moving price is $1.86. Get Rating
CNBX Pharmaceuticals, Inc. is a biopharmaceutical firm. It is engaged in the development, commercialization and discovery of novel cannabinoid products and innovative technology for the treatment and prevention of cancer. Eyal barad founded the company on September 15, 2004, and it is headquartered at Bethesda.
MarketBeat.com offers a FREE daily email newsletter